Scoop: Turing CEO and Shkreli ally Ron Tilles is out as CEO, R&D chief Salinas takes the helm and board vote looms
Regime change of some sort is underway at the controversial Turing Pharmaceuticals.
Tipped off on Friday that CEO and co-founder Ron Tilles — a close associate …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.